POLE2 and breast carcinoma: In conclusion, the overexpression of AURKB, GINS2, MCM10, UHRF1, POLE2, SPC24, and E2F2 in HER2-positive breast cancer patients with ALR showed that these hub genes could be potential prognostic biomarkers in such patients.